HealthEquity, Inc. (HQY)
USD 90.58
(2.99%)
USD 90.58
(2.99%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 999.58 Million USD | 16.0% |
| 2023 | 861.74 Million USD | 13.9% |
| 2022 | 756.55 Million USD | 3.13% |
| 2021 | 733.57 Million USD | 37.89% |
| 2020 | 531.99 Million USD | 85.21% |
| 2019 | 287.24 Million USD | 25.15% |
| 2018 | 229.52 Million USD | 28.68% |
| 2017 | 178.37 Million USD | 40.69% |
| 2016 | 126.78 Million USD | 44.31% |
| 2015 | 87.85 Million USD | 41.67% |
| 2014 | 62.01 Million USD | 34.56% |
| 2013 | 46.08 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 249.21 Million USD | 2.33% |
| 2024 Q4 | 262.38 Million USD | 5.28% |
| 2024 Q1 | 244.43 Million USD | 4.53% |
| 2024 FY | 999.58 Million USD | 16.0% |
| 2024 Q2 | 243.54 Million USD | -0.36% |
| 2023 Q2 | 206.14 Million USD | 0.23% |
| 2023 FY | 861.74 Million USD | 13.9% |
| 2023 Q1 | 205.67 Million USD | 1.17% |
| 2023 Q3 | 216.08 Million USD | 4.82% |
| 2023 Q4 | 233.84 Million USD | 8.22% |
| 2022 Q2 | 189.1 Million USD | 2.66% |
| 2022 FY | 756.55 Million USD | 3.13% |
| 2022 Q1 | 184.2 Million USD | -2.11% |
| 2022 Q4 | 203.29 Million USD | 12.97% |
| 2022 Q3 | 179.95 Million USD | -4.84% |
| 2021 Q3 | 179.35 Million USD | 1.88% |
| 2021 Q2 | 176.03 Million USD | -7.35% |
| 2021 Q1 | 190.01 Million USD | -5.56% |
| 2021 Q4 | 188.16 Million USD | 4.92% |
| 2021 FY | 733.57 Million USD | 37.89% |
| 2020 Q2 | 86.62 Million USD | -0.49% |
| 2020 Q3 | 157.11 Million USD | 81.38% |
| 2020 Q4 | 201.2 Million USD | 28.06% |
| 2020 FY | 531.99 Million USD | 85.21% |
| 2020 Q1 | 87.05 Million USD | 14.88% |
| 2019 Q3 | 70.49 Million USD | -0.8% |
| 2019 Q4 | 75.77 Million USD | 7.49% |
| 2019 FY | 287.24 Million USD | 25.15% |
| 2019 Q1 | 69.9 Million USD | 15.67% |
| 2019 Q2 | 71.06 Million USD | 1.66% |
| 2018 Q4 | 60.43 Million USD | 6.42% |
| 2018 Q2 | 56.87 Million USD | 2.63% |
| 2018 Q1 | 55.42 Million USD | 18.39% |
| 2018 FY | 229.52 Million USD | 28.68% |
| 2018 Q3 | 56.78 Million USD | -0.16% |
| 2017 Q3 | 43.35 Million USD | -1.87% |
| 2017 Q2 | 44.18 Million USD | 0.39% |
| 2017 Q1 | 44.01 Million USD | 22.65% |
| 2017 FY | 178.37 Million USD | 40.69% |
| 2017 Q4 | 46.81 Million USD | 7.97% |
| 2016 Q1 | 29.85 Million USD | 20.02% |
| 2016 FY | 126.78 Million USD | 44.31% |
| 2016 Q4 | 35.88 Million USD | 17.44% |
| 2016 Q3 | 30.55 Million USD | 0.2% |
| 2016 Q2 | 30.49 Million USD | 2.16% |
| 2015 Q3 | 21.86 Million USD | 4.65% |
| 2015 Q4 | 24.87 Million USD | 13.76% |
| 2015 FY | 87.85 Million USD | 41.67% |
| 2015 Q1 | 20.23 Million USD | 17.89% |
| 2015 Q2 | 20.89 Million USD | 3.26% |
| 2014 Q4 | 17.16 Million USD | 12.55% |
| 2014 FY | 62.01 Million USD | 34.56% |
| 2014 Q3 | 15.24 Million USD | 1.78% |
| 2014 Q1 | 14.62 Million USD | 0.0% |
| 2014 Q2 | 14.98 Million USD | 2.45% |
| 2013 FY | 46.08 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Accolade, Inc. | 414.29 Million USD | -141.276% |
| Bullfrog AI Holdings, Inc. Common Stock | 65 Thousand USD | -1537726.154% |
| BrightSpring Health Services, Inc. Common Stock | 8.82 Billion USD | 88.675% |
| CareCloud, Inc. | 117.05 Million USD | -753.917% |
| CareMax, Inc. | 751.1 Million USD | -33.083% |
| Definitive Healthcare Corp. | 251.41 Million USD | -297.584% |
| Health Catalyst, Inc. | 295.93 Million USD | -237.769% |
| iCoreConnect Inc. | 8.15 Million USD | -12162.485% |
| Inovalon Holdings, Inc. | 667.52 Million USD | -49.745% |
| Omnicell, Inc. | 1.14 Billion USD | 12.861% |
| Progyny, Inc. | 1.08 Billion USD | 8.177% |
| R1 RCM Inc. | 2.25 Billion USD | 55.657% |
| Schrödinger, Inc. | 216.66 Million USD | -361.349% |
| Simulations Plus, Inc. | 70.01 Million USD | -1327.716% |
| Streamline Health Solutions, Inc. | 22.59 Million USD | -4323.734% |
| SCWorx Corp. | 3.8 Million USD | -26170.748% |
| Sharecare, Inc. | 445.25 Million USD | -124.5% |
| Bullfrog AI Holdings, Inc. Warrants | 65 Thousand USD | -1537726.154% |
| SOPHiA GENETICS SA | 62.37 Million USD | -1502.647% |
| TruBridge, Inc. | 339.43 Million USD | -194.486% |
| Nutex Health, Inc. | 247.64 Million USD | -303.635% |
| Renalytix Plc | 2.28 Million USD | -43569.157% |
| GE HealthCare Technologies Inc. | 19.55 Billion USD | 94.888% |
| Aclarion, Inc. | 75.4 Thousand USD | -1325541.876% |
| Forian Inc. | 20.48 Million USD | -4780.479% |
| HeartBeam, Inc. | - USD | -Infinity% |
| GeneDx Holdings Corp. | 202.56 Million USD | -393.462% |
| GoodRx Holdings, Inc. | 750.26 Million USD | -33.231% |
| 10x Genomics, Inc. | 618.72 Million USD | -61.555% |
| Zhongchao Inc. | 19.43 Million USD | -5043.51% |
| HealthStream, Inc. | 279.06 Million USD | -258.194% |
| Augmedix, Inc. | 44.85 Million USD | -2128.485% |
| MSP Recovery, Inc. | 7.7 Million USD | -12873.225% |
| Spok Holdings, Inc. | 139.02 Million USD | -618.998% |
| Privia Health Group, Inc. | 1.65 Billion USD | 39.702% |
| EUDA Health Holdings Limited | 3.7 Million USD | -26868.793% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 8.82 Billion USD | 88.675% |
| Sharecare, Inc. | 445.25 Million USD | -124.5% |
| Premier, Inc. | 1.34 Billion USD | 25.756% |
| Certara, Inc. | 354.33 Million USD | -182.101% |
| GeneDx Holdings Corp. | 202.56 Million USD | -393.462% |
| Ontrak, Inc. | 12.74 Million USD | -7744.205% |
| SHL Telemedicine Ltd. | 57.07 Million USD | -1651.357% |
| CareCloud, Inc. | 117.05 Million USD | -753.917% |
| OneMedNet Corporation | 1.02 Million USD | -97740.358% |
| HeartBeam, Inc. | - USD | -Infinity% |
| EUDA Health Holdings Limited | 3.7 Million USD | -26868.793% |
| CareCloud, Inc. | 117.05 Million USD | -753.917% |
| Mangoceuticals, Inc. | 731.49 Thousand USD | -136550.248% |
| CareMax, Inc. | 751.1 Million USD | -33.083% |
| Healthcare Triangle, Inc. | 33.2 Million USD | -2910.532% |
| National Research Corporation | 148.58 Million USD | -572.76% |
| Aclarion, Inc. | 75.4 Thousand USD | -1325541.876% |
| OptimizeRx Corporation | 71.52 Million USD | -1297.603% |